WVSHP Logo Contact Information
News & Events

News from WVSHP

2018 WVSHP Annual Meeting Dates Announced SAVE THE DATE!2018 Annual Meeting April 6th and 7th Embassy Suites, Charleston, WV Registration to be available in January (Click for more...)

News from elsewhere...
A mathematic model and experimental verification of optimal nozzle diameter in needle-free injection 12/9/2017 6:05:01 PM December 09, 2017 Needle-free injection, as an alternative drug delivery strategy, owns great potential. It is able to reduce complaints about needle phobia and avoid the occurring of accidental needle stick injuries. The nozzle diameter is inherently important in determining the injection dose, injection depth and pain associated with needle-free injections. In this work, needle-free injectors with nozzle diameters of 0.17 mm, 0.20 mm, 0.30 mm, 0.40mm, 0.50 mm were studied in the simulation and experiment. (Click for more...) Characterization of the hydrodynamics in a miniaturized dissolution apparatus 12/9/2017 6:05:01 PM December 09, 2017 The hydrodynamics of a miniaturized dissolution apparatus was characterized using computational fluid dynamics (CFD) simulations and analyzed in relation to the biorelevance and robustness of measurements of drug dissolution and precipitation kinetics from supersaturated drug solutions. The effect of using three different agitator geometries operated at 50, 100, 150 and 200 RPM as well as different positioning of an UV probe in the vessel was systematically evaluated. The CFD simulations were validated using a particle streak velocimetry experiment. (Click for more...) Understanding the Factors that Control the Quality of Mini-tablet Compression: Flow, Particle Size and Tooling Dimension 12/9/2017 6:05:01 PM December 09, 2017 Despite the increasing importance of mini-tablet for its advantages as pediatric formulations and in modified release applications, its popularity is limited due to the lack of formulation and processing knowledge in developing such dosage forms. In this study, common grades of microcrystalline cellulose and roller compacted granules with a range of powder properties were used to evaluate the critical material properties required for the successful manufacturing of 1.7 mm mini-tablets. (Click for more...) Reaching consistent positive patient and cost outcomes 12/9/2017 12:05:01 AM December 08, 2017 (Click for more...) Measuring pharmacy technician impact on desired outcomes 12/9/2017 12:05:01 AM December 08, 2017 (Click for more...) First-hand knowledge of the technician’s value 12/9/2017 12:05:01 AM December 08, 2017 (Click for more...) With Aetna deal, CVS looks to turn stores into health care hubs 12/8/2017 9:00:01 AM December 08, 2017 Larry Merlo, CEO of CVS Health, hopes the company's planned $69 billion acquisition of insurer Aetna will lead to a national network of community medical clinics serving as "America's front door to quality health care." Craig Garthwaite, a professor at Northwestern's Kellogg School of Management, says that CVS is "expanding the retail clinics so they won't be quite urgent care, but they'll resemble a direct primary care facility." The assumption is that customers, especially those covered by Aetna insurance policies, will seek more of their basic health care at an expanded CVS clinic. (Click for more...) FDA-required studies of approved drugs make a big difference for public health 12/8/2017 9:00:01 AM December 08, 2017 FDA is committed to ensuring that industry fulfills its post-marketing requirements (PMRs) and post-marketing commitments (PMCs), writes Peter Stein, deputy director, Office of New Drugs, at FDA's Center for Drug Evaluation and Research. In addition, the agency strives to make sure that the post-market studies are transparent to the public and conducted promptly. According to FDA's most recent Federal Register notice on the status of PMRs and PMCs, most PMRs (85%) and PMCs (77%) are moving toward completion according to the original agreed-upon schedule. (Click for more...) Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation 12/8/2017 9:00:01 AM December 08, 2017 Phase III clinical testing evaluated the effect of letermovir in preventing cytomegalovirus (CMV) infection, which commonly occurs after allogeneic hematopoietic-cell transplantation. Study participants were randomly assigned to take either the antiviral, which inhibits the CMV–terminase complex, or a placebo through week 14 after the procedure. Investigators were interested to discover how many of their 495 patients who had no detectable CMV DNA at randomization presented with clinically significant CMV through week 48 post-transplant. (Click for more...) Risk of rotavirus nosocomial spread after inpatient pentavalent rotavirus vaccination 12/8/2017 9:00:01 AM December 08, 2017 Researchers at Seattle Children's Research Institute, along with collaborators at CDC and the University of Seattle pediatrics department, examined the issue of rotavirus vaccination among the youngest patients. The immunization is recommended before 104 days of life, but premature or sick infants who are hospitalized risk missing the deadline. In this prospective single-site study, the team considered 385 babies receiving intensive care treatment within the first 104 days after birth. (Click for more...) Hemophilia B gene therapy with a high-specific-activity factor IX variant 12/8/2017 9:00:01 AM December 08, 2017 Routine—but sometimes ineffective—care for hemophilia B, a bleeding disorder caused by a deficiency or dysfunction of coagulation factor IX, involves administering multiple weekly infusions of exogenous factor to prevent or stop bleeding. Researchers suspected that a single vector infusion to maintain factor IX coagulant activity above the level necessary to prevent spontaneous bleeding might prove to be a better option. To investigate, they launched a Phase I-IIa clinical trial assessing the safety of low-dose SPK-9001, a vector expressing a high-specific-activity factor IX. (Click for more...) Cities, counties and schools sidestep FDA Canadian drug crackdown, saving millions 12/8/2017 9:00:01 AM December 08, 2017 Dozens of cities, counties and school districts across the country have quietly found a solution to soaring drug prices they say protects their budgets and saves workers money. They are helping their employees buy medicines from pharmacies in Canada and overseas, where prices are up to 80% cheaper. The numbers are growing, even though FDA says the practice of importing prescription drugs is illegal and is stepping up enforcement. So far, the agency has made no move to shut down these employee benefit programs. (Click for more...) Trend toward self-management fuels growth of diabetes device sales 12/8/2017 9:00:01 AM December 08, 2017 With the increasing trend of self-management of diabetes, blood glucose meters are increasingly being utilized to help patients adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a regular basis. The global diabetes care devices market is expected to grow at a compound and annual growth rate of 5.3% from 2017 to 2022 to reach $26.7 billion Research and Markets reported in its "Diabetes Care Devices Market — Global Opportunity Analysis and Industry Forecast (2017-2022)" report released on November 30. (Click for more...) CVS Health survey reveals majority of Americans want change to improve the state of U.S. health care 12/8/2017 9:00:01 AM December 08, 2017 Fifty-six percent of Americans say the U.S. health care system does not work well for them, while 73% agree the system is in need of reform, according to a national survey of about 2,200 adults. The survey, conducted on behalf of CVS Health in October, found that of those Americans frustrated by the current state of U.S. health care, 65% say it is too expensive, and the affordability of health care, health insurance, and prescription drugs top the list of their most urgent concerns. Despite generally negative views of the U.S. (Click for more...) FDA proposes drug development guidance for rare pediatric diseases 12/8/2017 9:00:01 AM December 08, 2017 FDA, in collaboration with the European Medicines Agency, has issued a draft guidance to simplify the procedure of developing drugs for rare pediatric disorders. The new approach reduces the number of patients on placebo by allowing companies to collaborate and test multiple drug products in the same clinical trial. The draft guidance used Gaucher's as a disease model, but FDA added that the proposal could be extended to other rare pediatric disorders. The guidance is available for comment for about 2 months, after which FDA will release its final determinations. (Click for more...) Maryland to receive $10m from Mylan in Medicaid fraud settlement 12/8/2017 9:00:01 AM December 08, 2017 Maryland Attorney General Brian Frosh said Thursday that the state will receive almost $10 million from Mylan as part of the company's settlement with the Department of Justice over claims that it overbilled Medicaid for EpiPens. The $465 million settlement resolved allegations that the drug maker improperly classified the life-saving allergy medication injections, a brand-name drug, as a generic medication between 2010 and 2016 to avoid paying higher rebates on the devices. (Click for more...) Advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation 12/8/2017 9:00:01 AM December 08, 2017 FDA announced Thursday three new, significant policy documents to further the agency's approach to the development and proper oversight of innovative digital health tools. The new guidances—two draft and one final—address, in part, key provisions of the 21st Century Cures Act that offer additional clarity about where FDA sees its role in digital health and also where the agency does not see a need to be involved. The first draft guidance, "Clinical and Patient Decision Support Software," details the agency's approach to clinical decision support software (CDS). (Click for more...) Amazon pulls pharmacy wholesaler application in Maine 12/8/2017 9:00:01 AM December 08, 2017 Amazon has canceled a pharmaceutical wholesaler application in Maine. RBC analysts said in a research note that the canceling of the Maine license reduces the likelihood that Amazon will enter the pharmacy business, which they called "a positive for the pharmacies and drug supply chain." It is possible for companies to cancel licenses and then file for a different type of license with the state, however. Amazon has gained approval from at least 12 state pharmacy boards to become a wholesale distributor, according to recent media reports. (Click for more...) DEA operation targets 26 pharmacies in three states in attack against illicit opioid trafficking 12/7/2017 9:00:02 AM December 07, 2017 DEA's Los Angeles Field Division recently announced Operation Faux Pharmacy, a multi-pronged initiative aimed at attacking the opioid epidemic by targeting rogue pharmacies throughout southern California, Hawaii, and Nevada. DEA investigations over the last year identified as many as 26 pharmacies in these areas that may have operated outside the bounds of legitimate medicine. (Click for more...) Contemporary hormonal contraception and the risk of breast cancer 12/7/2017 9:00:02 AM December 07, 2017 New research out of Denmark shows that the risk of breast cancer was higher among women who currently or recently used contemporary hormonal contraceptives compared with women who had never used hormonal contraceptives, with the risk increasing with longer duration of use. The researchers note, however, the absolute increases in risk were small. For the prospective cohort study, 1.8 million women aged 15–49 years were followed for an average of 10.9 years. During the study period, 11,517 cases of breast cancer occurred. (Click for more...) Prevention, detection, evaluation, and management of high blood pressure in adults 12/7/2017 9:00:02 AM December 07, 2017 The American College of Cardiology (ACC) and American Heart Association (AHA), in partnership with other groups, have issued updated standards related to hypertension in adults. The guideline offers more than 100 recommendations covering diagnosis, treatment, and management. Among the key points, clinicians are advised to make one of four diagnoses based on blood pressure readings. Measurements meeting the target rate of 120/80 mm Hg should be considered normal, but a top number of 120–129 indicates "elevated" blood pressure. (Click for more...) Intranasal ketamine or fentanyl for children 12/7/2017 9:00:02 AM December 07, 2017 In pediatric patients presenting with single-extremity fractures, new findings show that intranasal ketamine delivers comparable pain relief to intranasal fentanyl—but also more adverse events. A total of 82 children were included in the study, which randomized them equally to ketamine or fentanyl. All 41 of the children who received ketamine analgesia experienced minor adverse events, versus 61% of those who were given fentanyl. Additionally, the cumulative number of adverse effects—including unpleasant taste in mouth, dizziness, and sleepiness—was 2.2 times higher in the ketamine group. (Click for more...) New mega-deal shows how health insurers are taking over access to medical care 12/7/2017 9:00:02 AM December 07, 2017 UnitedHealth Group, announced Wednesday that it would buy a network of 300 primary care and specialist clinics from dialysis giant DaVita for $4.9 billion, in the latest deal reshaping the business of health insurance. The deal comes days after CVS Health agreed to buy Aetna for $69 billion. Both acquisitions reflect strategies to try to own major entry points into health care, whether it is pharmacists or primary care physicians, so that insurers can better coordinate care, keep people healthy and hopefully control rising costs. (Click for more...) CVS Pharmacy launches free, same-day prescription delivery in Manhattan 12/7/2017 9:00:02 AM December 07, 2017 CVS Pharmacy has unveiled free, same-day delivery for prescriptions and some OTC products in Manhattan. The company plans to launch same-day delivery in additional cities and next-day, nationwide delivery early next year. "Free, same-day prescription delivery gives customers the option of having the pharmacy they trust deliver right to them at their homes or work in Manhattan," said Helena Foulkes, executive vice president, CVS Health, and president, CVS Pharmacy. (Click for more...) Walgreens launches Flu Index for 2017-18 season 12/7/2017 9:00:02 AM December 07, 2017 Walgreens launched on Wednesday its first Flu Index of the 2017–18 influenza season. The Walgreens Flu Index, now in its fourth year, uses prescription data for antiviral drugs used to treat influenza across Walgreens and Duane Reade locations nationwide and Walgreens locations in Puerto Rico. The weekly report ranks the top markets and states for influenza activity in the United States. For the week of December 2, 2017, the top five states with influenza activity were Texas, Arkansas, Tennessee, West Virginia, and Wyoming, according to the index. (Click for more...) Walgreens takes stake in Chinese pharmacy chain 12/7/2017 9:00:02 AM December 07, 2017 Walgreens Boots Alliance says it will take a 40% minority stake in Sinopharm Holding Guoda Drugstores Co. of China. The company, a subsidiary of China National Accord Medicines Corp., has more than 3,500 stores and employs nearly 20,000 people. Walgreens is acquiring the share for about $418 million. "We have had a presence in China for around 10 years, initially through Alliance Boots, and we are excited about the opportunity to further invest in the country's fast-growing retail pharmacy sector," said Walgreens CEO Stefano Pessina. (Click for more...) HDA: Drug chains still pharmaceutical distributors' biggest customers 12/7/2017 9:00:02 AM December 07, 2017 Chain pharmacies accounted for nearly 30% of all sales to U.S. pharmaceutical distributors last year, according to the 88th Edition HDA Factbook (2017–18). Additionally, drug distributors handled an increased percentage of U.S. pharmaceutical sales in 2016, with 95.7% of U.S. pharma sales going to market via drug wholesalers, an increase about 2% from a year ago. (Click for more...) McKesson RxO team identifies five health system pharmacy trends to watch in 2018 12/7/2017 9:00:02 AM December 07, 2017 The McKesson RxOTM team has identified five trends it believes will affect hospital and health system pharmacies in the coming year. These five trends are: renewed interest in the 340B Drug Pricing Program to address growing oversight and reimbursement changes, access to data and analytics to drive outcomes and operational efficiency, continued growth in the specialty pharmaceuticals market, health system pharmacies generating revenue, and consolidation driving centralized service centers. (Click for more...) CMS Office of the Actuary releases 2016 national health expenditures 12/7/2017 9:00:02 AM December 07, 2017 In 2016, overall national health spending increased 4.3% following 5.8% growth in 2015, according to a study by the Office of the Actuary at CMS. Following Affordable Care Act coverage expansion and significant prescription drug spending growth in 2014 and 2015, health care spending growth decelerated in 2016. The report concludes that the 2016 expenditure slowdown was broadly based as growth for all major payers (private health insurance, Medicare, and Medicaid) and goods and service categories (hospitals, physician and clinical services, and prescription drugs) slowed in 2016. (Click for more...) Aetna's outgoing CEO set to reap about $500 million if CVS deal closes 12/7/2017 9:00:02 AM December 07, 2017 Mark T. Bertolini, CEO of Aetna, is poised to receive about $500 million when he leaves his company if it successfully merges with CVS Health in a $69 billion deal. His substantial payout comes largely because Bertolini was a major stakeholder in his own company, where he started in 2003 as head of specialty products. At the agreed-upon $207-a-share deal price, more than $230 million could come from already-vested stock appreciation rights Bertolini holds for Aetna shares, and the Aetna common stock he currently holds would be valued at about $190 million. (Click for more...) CVS boss Larry Merlo's path from corner pharmacy to C-suite 12/6/2017 9:00:01 AM December 06, 2017 Larry Merlo, CVS's CEO since 2011, is a former pharmacist from rural Pennsylvania who has now engineered the year's largest and arguably most surprising health care deal with his firm's purchase of Aetna. The deal puts Merlo in charge of the company's PBM, its network of 10,000 pharmacies, and Aetna's coverage of about 22.2 million members enrolled in employer plans, Medicare, Medicaid, and other plans. Together, the companies have roughly $240 billion in annual sales. Merlo has cast the acquisition as an antidote to soaring health-care costs. "The current U.S. (Click for more...) FDA commissioner updates on Puerto Rico-related medical product shortages 12/6/2017 9:00:01 AM December 06, 2017 In an update on the status of medical product shortages after Hurricane Maria hit Puerto Rico earlier this year, FDA Commissioner Scott Gottlieb said that progress is being made, but more still needs to be done. As power is being restored across the island, some major medical product manufacturing facilities are coming back online and stabilizing their production. (Click for more...) Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate 12/6/2017 9:00:01 AM December 06, 2017 The safety and immunogenicity of a purified formalin-inactivated Zika virus vaccine (ZPIV) candidate was evaluated through a series of Phase I trials. A total of 55 healthy volunteers at three sites around the United States were randomized to the experimental drug—which had triggered antibody protection in earlier animal studies—and 12 were assigned to receive a placebo vaccine. Vaccinations were administered intramuscularly on days 1 and 29, with researchers documenting adverse events and envelope microneutralization titres up to day 57. (Click for more...) Simple Diagnostics recalls some Pharmacist Choice Alcohol Prep Pads 12/6/2017 9:00:01 AM December 06, 2017 Simple Diagnostics announced a voluntary recall of three lots of Pharmacist Choice Alcohol Prep Pads due to a lack of sterility assurance and other quality issues. The alcohol prep pads, made by Foshan Flying Medical Products Co. Ltd. of China, are used by health care professionals and patients for preparation of the skin prior to injection as well as in first aid. The affected lots (SD2070421201, SD2070420925, and SD2070420601) were distributed between October 18, 2016, and July 19, 2017. (Click for more...) FDA approves semaglutide for type 2 diabetes 12/6/2017 9:00:01 AM December 06, 2017 FDA has approved semaglutide (Ozempic—Novo Nordisk) as an adjunct to diet and exercise for the treatment of type 2 diabetes in adults. The drug, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, was approved in 0.5-mg and 1.0-mg doses, to be administered once a week with a dedicated prefilled pen device. Following approval, Novo Nordisk must conduct a pediatric trial in individuals younger than age 18 years and add semaglutide to a 15-year medullary thyroid carcinoma registry that includes all of the long-acting GLP-1 products. (Click for more...) Medication errors for admitted patients drop when pharmacy staff take drug histories in ED 12/6/2017 9:00:01 AM December 06, 2017 Although it is long-held practice for nurses and doctors to record patients' medical history in the emergency department (ED), research suggests that fewer mistakes ensue when this job is handed to pharmacy professionals. The study, spearheaded by Cedars-Sinai Hospital in Los Angeles, involved more than 300 patients with past heart failure or other serious conditions who were taking at least 10 prescription medications. (Click for more...) APhA teams with Kroger, Solera to prevent diabetes 12/6/2017 9:00:01 AM December 06, 2017 The APhA Foundation is working with The Kroger Co. and Solera Health on a program to reduce the incidence of diabetes through community pharmacies. For "Project IMPACT: Diabetes Prevention," the APhA Foundation was selected by CDC to create infrastructure in pharmacies to increase access to the CDC-recognized National Diabetes Prevention Program (DPP) evidence-based lifestyle change program. In partnership with Kroger and Solera, the foundation plans to deliver the National NPP curriculum to at least 7,500 at-risk adults in underserved communities. (Click for more...) Encouraging new uses for old drugs 12/6/2017 9:00:01 AM December 06, 2017 Follow-on innovation for low-cost generic drugs could improve health outcomes while lowering health care expenditures, but the current drug patent system is poorly designed to encourage discoveries of new indications for off-patent drugs, according to a new article published in the Journal of the American Medical Association. The researchers suggest three potential solutions to promote more discovery of these new uses, including government funding of research, prizes for discovery, and leveraging existing data. (Click for more...) Anxiety and nerve medication abuse increasing in West Virginia 12/6/2017 9:00:01 AM December 06, 2017 Abuse of benzodiazepines in West Virginia is increasing, according to a state official. Brad Henry, MD, president of the West Virginia State Medical Association, says the average number of benzodiazepine prescriptions in the state is 71.9 prescriptions per 100 people. The average rate nationwide is 37.4 per 100 people. Henry notes that in West Virginia, which has the third highest opioid prescribing rate in the country, "most of the overdose deaths we see are multiple drugs. (Click for more...) FDA's expedited programs and clinical development times for novel therapeutics 12/6/2017 9:00:01 AM December 06, 2017 In a research letter, health economists from Brigham and Women's Hospital, Boston, report on their investigation of clinical development times within each of FDA's four expedited drug approval times separately and between drugs qualifying for any vs. no expedited program. According to the findings, the median time from Investigational New Drug (IND) application to FDA approval was 0.9 years shorter for drugs with any expedited program, compared with those without one. (Click for more...) New Wisconsin law requires pharmacies to track customers who buy pseudoephedrine 12/6/2017 9:00:01 AM December 06, 2017 Wisconsin pharmacists are required to keep track of who purchases cold and allergy medicines containing pseudoephedrine and how much they are buying each month, but until recently those records were not shared with other pharmacies. Now, a new law signed by Gov. Scott Walker requires pharmacists to enter the customers' information into the National Precursor Log Exchange. "Some pharmacies use a written method, so they write it out in a book form. Some scan IDs, which logs the information electronically in their record," said Thad Schumacher, owner of Fitchburg Family Pharmacy. (Click for more...) PEPFAR: FDA approves 200th HIV/AIDS therapy 12/6/2017 9:00:01 AM December 06, 2017 FDA Commissioner Scott Gottlieb notes that late in November the agency approved — or tentatively approved — the 200th antiretroviral drug application, including 30 solid formulations specific for children, under the President’s Emergency Plan for AIDS Relief (PEPFAR). The plan was launched in 2003 to address the global HIV/AIDS epidemic by stimulating the development of new HIV therapies, many of which were new combinations of generic medicines and were purchased with American funds at low cost, to expand opportunities in countries that lacked good access to treatment. (Click for more...) Active Mediated Transport of Chloramphenicol and Thiamphenicol in a Calu-3 Lung Epithelial Cell Model 12/6/2017 12:05:01 AM December 05, 2017 Pulmonary administration enables high local concentrations along with limited systemic side-effects, but not all ATB could be good candidates. In this perspective, diffusion of the ATB chloramphenicol (CHL) and thiamphenicol (THA) through the lung has been evaluated to re-assess their potential for pulmonary administration. The apparent permeability (Papp) was evaluated with the Calu-3 cell model. Influence of drug transporters was assessed with the PSC-833, MK-571, and KO-143 inhibitors. The influence of CHL and THA on the cell uptake of rhodamin123 and fluorescein was also evaluated. (Click for more...) On the production of chitosan coated PCL nanoparticles in a Confined Impinging Jets Reactor 12/6/2017 12:05:01 AM December 05, 2017 This work is focused on the synthesis of polycaprolactone nanoparticles, coated with chitosan, in a confined impinging jets reactor using the solvent displacement method. The role of the various reacting species was investigated, evidencing that a biocompatible polymer, e.g. polycaprolactone, is required to support chitosan to obtain a mono-modal particle size distribution, with low particle diameters. (Click for more...) Dietary supplements may be overlooked as cause of liver injury 12/6/2017 12:05:01 AM December 01, 2017 While some drugs are well recognized to damage the liver, dietary supplements should not be overlooked as a potential cause. According to data from the U.S. Drug-Induced Liver Injury Network (DILIN), 15.5% of reported cases of drug-induced liver injury are due to use of herbals and other dietary supplements, with 35% resulting from bodybuilding products and 65% from herbals and other supplements.1 Reporting of cases resulting from dietary supplement use increased from 7% to 20% during the first 10 years of the DILIN. (Click for more...) Increased EHR use has advantages, but also patient safety barriers 12/6/2017 12:05:01 AM December 01, 2017 Responders to the ASHP National Survey of Pharmacy Practice in Hospital Settings: Prescribing and Transcribing—20161 conveyed that health care institutions across the country are increasing their use of information technology (IT). This development has contributed to the expansion of pharmacy services and has offered several clinical advantages in both inpatient and outpatient settings. However, with 99% of hospitals now virtually paperless and operating on electronic health records (EHRs), some unexpected challenges in patient safety have emerged. (Click for more...) CDC’s ACIP recommends preferred use of new herpes zoster vaccine 12/6/2017 12:05:01 AM December 01, 2017 CDC’s Advisory Committee on Immunization Practices (ACIP) met on October 25–26 in Atlanta to discuss the latest information on vaccines and immunization practices. ACIP voted on vaccination recommendations for herpes zoster (HZ) vaccines and mumps-containing vaccines. ACIP also voted to approve the 2018 immunization schedules and discussed updates on many other vaccine-related issues. (Click for more...) Pharmacists in Action: Build your community of practitioners, scientists at APhA2018; APhA’s Mentor360; APhA member Staci-Marie Norman; learning Ayurveda in Kerala, India; compounding 12/6/2017 12:05:01 AM December 01, 2017 (Click for more...) New therapeutic agents marketed in 2017: Part 2 12/6/2017 12:05:01 AM December 01, 2017 To provide information about the most important properties of new FDA-approved therapeutic agents marketed in 2017. (Click for more...) Life-threatening errors with compounded flecainide oral suspension in children 12/6/2017 12:05:01 AM December 01, 2017 Flecainide is an oral class 1c antiarrhythmic drug that may be used to treat atrial fibrillation or supraventricular tachycardia, particularly when conventional treatment agents fail. Because it is available commercially only as oral tablets, it must be compounded into a suspension when needed for infants and small children. Unfortunately, errors during preparation and dosing of the suspension have occasionally led to serious overdoses that resulted in cardiac emergencies and required immediate therapeutic intervention. (Click for more...) Hospitals can improve high-alert med safety procedures with self-assessment 12/6/2017 12:05:01 AM December 01, 2017 Hospitals in the United States are required to identify and maintain active lists of high-alert medications, which isn’t hard to do. But when it comes to the next step of developing safety procedures for high-alert medications, the task can become more challenging. (Click for more...) Determining duration: How long to prescribe postoperative opioids 12/6/2017 12:05:01 AM December 01, 2017 In September, JAMA Surgery published online evidence-based recommendations for optimizing the duration of opioid treatment for pain following common surgical procedures.1 The authors proposed that opioid prescriptions postsurgery should balance adequate pain management against the duration of treatment and offered guidance for determining the appropriate length of opioid prescriptions. (Click for more...) Stopping aspirin treatment can increase risk of CV events 12/6/2017 12:05:01 AM December 01, 2017 Results of a nationwide, population-based cohort study1 published in Circulation in September 2017 suggested that patients using low-dose aspirin who discontinued treatment were at a 37% increased risk of cardiovascular (CV) events compared with those who continued treatment. An increased risk of CV events was observed in those using aspirin for either secondary or primary CV prevention. (Click for more...) Give yourself the gift of positive perspective 12/6/2017 12:05:01 AM December 01, 2017 As 2017 comes to a close, it is natural to look back on the year and reflect on what occurred. Unfortunately, it is human nature to focus on just the bad things that happen. This tendency may have helped ensure our survival in primitive times, but nowadays it’s likely to lead to fear of taking risks and decision paralysis. By being mindful of keeping a positive perspective on past challenges, we set ourselves up for success when faced with new challenges. (Click for more...) Home medical equipment and tests 12/6/2017 12:05:01 AM December 01, 2017 This section of Pharmacy Today’s Self-Care Survey is reprinted from the full survey results. These were published in the February 2017 issue of the magazine and are available online at http://pharmacytoday.org. (Click for more...) How useful is flaxseed in improving lipid profiles? 12/6/2017 12:05:01 AM December 01, 2017 Seeds from flax (Linum usitatissimum) have been studied for their health benefits, including mitigation of cardiovascular disease (CVD).1 Flaxseed may improve CVD risk by modestly improving lipid profiles. Multiple mechanisms may be involved, including antioxidant and hypocholesterolemic effects related to soluble fiber, lignin, and/or high α-linolenic acid (ALA) content.1,2–4 (Click for more...) What you should know about 2018 Medicare prescription drug plans 12/6/2017 12:05:01 AM December 01, 2017 Open enrollment for Medicare plans ends on December 7, and 2018 coverage begins on January 1. While no major changes have been made from 2017, there are some things you should know to help your Medicare patients this year—and some things to keep an eye out for in 2019. (Click for more...) At rural clinic in Oregon, pharmacist restarts widower’s meds under a CPA 12/6/2017 12:05:01 AM December 01, 2017 “Howard” lost his wife to lung cancer 2 years ago. When he still felt depressed and anxious months after her death, he started antidepressant and antianxiety medications to alleviate his symptoms. Last year, however, Howard and his providers at Monroe Health Center in Monroe, OR, agreed that he was doing better and tapered off his medications. (Click for more...) Capitol Hill Health Fair promotes pharmacists as providers 12/6/2017 12:05:01 AM December 01, 2017 In the brightly lit foyer at the center of the maze-like Rayburn House Office Building in Washington, DC, pharmacists and student pharmacists provided free health care screenings and influenza vaccinations as well as education on the provider status legislation to the public, including Members of Congress and their staff, on a bustling Wednesday during American Pharmacists Month. (Click for more...) Talk to patients about how alcohol and medications #DONTMIX 12/6/2017 12:05:01 AM December 01, 2017 The holiday season has begun, and for many, that means alcohol is flowing. While it’s good to celebrate the holidays, mixing alcohol with medication is not advised—and this goes for many prescription medications as well as OTC medications that contain acetaminophen. As pharmacists know, mixing medications with alcohol can cause adverse reactions and can stop the medication from working. (Click for more...) Gastroenterology, reproductive medicine, COPD 12/6/2017 12:05:01 AM December 01, 2017 Orlando, October 13–18, 2017 (Click for more...) New lipid guidelines shift focus back to LDL goals 12/6/2017 12:05:01 AM December 01, 2017 Earlier this year, the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE) released clinical practice guidelines for management of dyslipidemia and prevention of cardiovascular disease (CVD). Unlike the 2013 American Heart Association (AHA)/American College of Cardiology (ACC) guidelines, which shifted the focus from LDL targets to varying intensities of statin therapy for select patients, the AACE/ACE guidelines discuss specific LDL targets. Of the 87 recommendations included, 45 are Grade A. (Click for more...) First single-dose antimicrobial agent approved for bacterial vaginosis 12/6/2017 12:05:01 AM December 01, 2017 Secnidazole (Solosec—Symbiomix Therapeutics) is the first oral antibiotic for bacterial vaginosis (BV) to be approved by FDA in more than a decade—and the only single-dose agent for treatment of this common infection. The next-generation antimicrobial comes as a foil packet of 2-g granules that are sprinkled onto applesauce, yogurt, or pudding and consumed within 30 minutes without chewing or crunching the granules. (Click for more...) Select agents may interact with non–vitamin K oral anticoagulants 12/6/2017 12:05:01 AM December 01, 2017 Concurrent use of amiodarone, fluconazole, rifampin, or phenytoin with non–vitamin K oral anticoagulants such as rivaroxaban (Xarelto—Bayer, Janssen), dabigatran (Pradaxa—Boehringer Ingelheim), or apixaban (Eliquis—Bristol-Myers Squibb) increased the risk of major bleeding compared with use of these anticoagulants alone in patients with nonvalvular atrial fibrillation (AF), according to a retrospective cohort study1 published in JAMA in October 2017. (Click for more...) Amid low pneumococcal vaccination rates, researchers find bright spots 12/6/2017 12:05:01 AM December 01, 2017 Vaccinating adults against pneumococcal disease remains an ongoing public health objective. According to statistics compiled by CDC, more than 95% of pneumococcal deaths in the United States occur in the adult population. Yet 80% of adults with conditions that put them at increased risk remain unvaccinated. (Click for more...) Drug shortages loom from hurricane-impaired manufacturing in Puerto Rico 12/6/2017 12:05:01 AM December 01, 2017 Small, fluid-filled bags known as “minibags” have been in short supply for years. Now, hospitals are feeling even more compromised from the shortage ever since production at Baxter facilities in Puerto Rico was hampered in September by Hurricane Maria. Baxter International makes a significant portion of I.V. solution products for the U.S. market. (Click for more...) Tech takes community pharmacy into the future 12/6/2017 12:05:01 AM December 01, 2017 STAFF AT KOMOTO PHARMACY IN DELANO, CA, have a morning routine. The first pharmacist to arrive fires up the pharmacy management system, and while pharmacy technicians start processing prescriptions in the queue, gears grind, cylinders spin, and gleaming robotic arms reach and grab medications in a soft gray honeycomb of carefully stocked cells. The pharmacy becomes a hive abuzz with the day’s tasks, its output overseen and reviewed by pharmacists who ensure that the right medications go into the right packages in the right amounts with the right labels for the right patients. (Click for more...) Final thoughts on my journey and our profession 12/6/2017 12:05:01 AM December 01, 2017 Nine years ago, I had just finished my first year and a half of co-ownership of Towncrest Pharmacy. I had left my safe and stable academic position and was pursuing my dream to create a community pharmacy practice that was inspired by my readings about Eugene White. I had learned so much in that first year as an owner that I thought a column about practice pearls might be of interest to other pharmacists. After I pitched the idea to several publications, the editor of Pharmacy Today called me, and the predecessor to MTM Pearls was born. (Click for more...) Board certification for community pharmacists grows alongside clinical services 12/6/2017 12:05:01 AM December 01, 2017 Before 2011, an applicable certification for pharmacists practicing in the community setting didn’t really exist. Then the Board Certified Ambulatory Care Pharmacist (BCACP) credential came along. (Click for more...) In a sea of change, pharmacists navigate opioid prescribing and dispensing 12/6/2017 12:05:01 AM December 01, 2017 “Wendy” has been taking a prescription opioid to manage pain from a back injury she sustained in an accident several months ago. But her primary care physician has refused to write further prescriptions and instead has referred her to a pain management clinic. The providers at the clinic won’t prescribe the dose she had been taking because it exceeds CDC recommendations. Wendy comes to the pharmacy in obvious pain and says she doesn’t understand why she’s being treated “like a criminal” when all she wants is to be able to work and take care of her children. (Click for more...) Pharmacy error leads to fatal medication mix-up 12/6/2017 12:05:01 AM December 01, 2017 Pharmacy errors can occur in many different ways. A recent case from Missouri reviewed several key sources of pharmacy error and eventually restored an aggravating damages claim in a pharmacy error case. (Click for more...) Effective treatment for early-stage COPD 12/6/2017 12:05:01 AM December 01, 2017 Use of once-daily tiotropium (Spiriva—Boehringer Ingelheim) in patients with mild to moderate COPD resulted in higher lung function measures and less annual decline in lung function compared with placebo, according to a study published in the New England Journal of Medicine. (Click for more...) Showcase: New approvals, indications, formulations, generic 12/6/2017 12:05:01 AM December 01, 2017 (Click for more...) Abundance, scarcity, and what lies ahead in 2018 12/6/2017 12:05:01 AM December 01, 2017 The final days of the year make most of us reflective, and 2017 has given us a lot upon which to reflect. (Click for more...) Making changes to help you have a better Today 12/6/2017 12:05:01 AM December 01, 2017 Over the years of my involvement with magazines and journals, I’ve often wondered whether publishers eavesdropped when pharmacists learned to “start low and go slow” with doses. In the same way, when we tweak Pharmacy Today, we do it incrementally, which I think is actually publisher code for “really, really slowly.” Lately, though, we’ve been making some great changes in Today to ensure we continue to have articles that are relevant, helpful, and meet your needs—well, today. (Click for more...) News You Can Use: FDA calls out kratom use risks; new AHA/ACC guidelines redefine high blood pressure; community pharmacists enhance care in patient-centered medical home; PTCB names SSgt Mary Johnson CPhT of the Year 12/6/2017 12:05:01 AM December 01, 2017 High blood pressure is now defined as a reading of 130/80 mm Hg, according to the first new comprehensive guidelines in more than a decade from the American Heart Association (AHA) and the American College of Cardiology (ACC). (Click for more...) New clinician resource available explains biological impact of aging on immunity and the importance of vaccines 12/5/2017 1:59:52 PM December 05, 2017 The American College of Physicians (ACP), the American Pharmacists Association (APhA), and the Gerontological Society of America (GSA), representing 220,000 clinicians, today released Aging and Immunity: The Important Role of Vaccines, a new resource highlighting the biological impact of aging on immunity. (Click for more...) Determining duration: How long to prescribe postoperative opioids 12/5/2017 9:38:08 AM December 05, 2017 In September, JAMA Surgery published online evidence-based recommendations for optimizing the duration of opioid treatment for pain following common surgical procedures. The authors proposed that opioid prescriptions postsurgery should balance adequate pain management against the duration of treatment and offered guidance for determining the appropriate length of opioid prescriptions. (Click for more...) Sanofi leads charge against counterfeits 12/5/2017 9:00:01 AM December 05, 2017 The World Health Organization reports that an estimated one in 10 medicines in poor countries are counterfeit and likely responsible for the deaths of tens of thousands of children from diseases such as malaria and pneumonia every year. It estimates that 100,000 to 1 million people die each year as a result of fake medication. Meanwhile the EU’s Intellectual Property Office says that €1.7bn in tax and social contributions are lost to the public authorities each year in Europe because of counterfeit medicines. (Click for more...) A new antibiotic weakness--drugs themselves help bacteria survive 12/5/2017 9:00:01 AM December 05, 2017 Antibiotic treatment is often life-saving, but new evidence shows that the medications sometimes work against themselves. Researchers reporting in Cell Host & Microbe explain how the drugs can both protect infectious bacteria by altering the natural combination of chemicals produced by the body as well as by compromising immune cells from defending against infections. The finding comes from a team led by James Collins of Massachusetts Institute of Technology (MIT). They infected mice with Escherichia coli, giving antibiotics to some and withholding them from others. (Click for more...) CDC influenza update: Influenza-like illness consultations rise above baseline 12/5/2017 9:00:01 AM December 05, 2017 CDC's most recent FluView report shows that seasonal influenza activity increased in the United States, with the proportion of people seeing their health care provider for influenza-like illness (ILI) above the national baseline for the first time this season. So far this season, influenza A(H3N2) viruses have been the predominant virus. For the week ending November 25, the proportion of people seeing their health care provider for ILI was 2.3%, just above the national baseline of 2.2%. (Click for more...) Does an ADHD link mean acetaminophen is unsafe in pregnancy? 12/5/2017 9:00:01 AM December 05, 2017 Recent years have seen questions and controversy swirl around the long-held practice of giving acetaminophen to women who experience fever, pain, or inflammatory conditions while pregnant. Research has suggested a possible relationship between frequent maternal acetaminophen use and increased chance of ADHD in the offspring. "Short term use, we have no reason to think it's bad," according to Prof. Eivind Ystrom, lead investigator of two pivotal studies conducted in Norway. (Click for more...) How will consumers fare if CVS and Aetna merge? 12/5/2017 9:00:01 AM December 05, 2017 The merger of CVS Health and Aetna would combine one of the country's biggest pharmacies with one of its largest health insurers. Executives at the firms say it will create a world where patients will get the "human touch," and that getting high-quality, low-cost medical care will be as close as your community pharmacy. (Click for more...) Walgreens redefines its brand 12/5/2017 9:00:01 AM December 05, 2017 Walgreens said Friday that as part of a brand repositioning, it is changing its tagline to "Trusted Since 1901" to emphasize its long heritage of serving customers. Plans call for the new tagline to be featured in all of the community pharmacy chain's television, online, and in-store advertising going forward. The Walgreens brand positioning is an effort to highlight the pharmacy's attributes of care, trust, and accessibility from the past 116 years. (Click for more...) Battle over Medi-Cal pay to pharmacies rolls on 12/5/2017 9:00:01 AM December 05, 2017 Although community pharmacists in Ventura County, CA, fear deep cuts in prescription reimbursements could force them to close their doors, Gold Coast Health Plan—which administers Medi-Cal coverage locally—says it will not seek to renegotiate the rates. Reimbursements began to fall after Gold Coast hired OptumRx last year to run its pharmaceutical efforts. Pharmacists who had been earning $10–$11 per prescription for Gold Coast medications found that amount dipping to $4–$5. (Click for more...) Meningitis B vaccine available to students, faculty and staff at UMass Amherst 12/5/2017 9:00:01 AM December 05, 2017 In response to two confirmed cases of meningitis B at UMass Amherst, CVS Health is offering meningitis B vaccines to students, faculty, and staff at the school. According to the company, CVS Pharmacy stores and MinuteClinic walk-in medical clinics have vaccines available to protect patients against the disease. CDC has determined that the strains of the meningococcal bacteria that caused the two students' infections are closely related. UMass Amherst students who have not been vaccinated are encouraged to get vaccinated. (Click for more...) Drugs giants warn of Brexit 'disruption' to their supply chain 12/5/2017 9:00:01 AM December 05, 2017 U.K. pharmaceutical companies and organizations fear that Britain's withdrawal from the European Union (Brexit) could trigger a major disruption in medicine delivery to the patient community. AstraZeneca has voiced its concerns to a government panel looking into potential fallout from the move. The Association of the British Pharmaceutical Industry (ABPI) has joined it in ringing the alarm, as have multinational firms like Johnson & Johnson and Roche. (Click for more...) Colorado lifts restrictions for treating hepatitis C patients 12/5/2017 9:00:01 AM December 05, 2017 Under pressure from health officials and civil rights advocates, Colorado's Medicaid department has removed restrictions that prevented some hepatitis C patients from receiving treatment. In order to qualify for groundbreaking antiviral therapy that minimizes adverse events and resolves 90% of hepatitis C cases, patients until now had to have advanced liver damage. (Click for more...) Montana sues Purdue over opioid epidemic 12/5/2017 9:00:01 AM December 05, 2017 Montana is the latest state to sue Purdue Pharma, maker of oxycodone (OxyContin). In the suit, Montana Attorney General Tim Fox alleged that Purdue misrepresented the likelihood that long-term use of its opioid analgesics would lead to addiction. "Pharmaceutical companies that knowingly and deceptively harm consumers must be held accountable," Fox said. In a statement, Purdue denied the claims. The company has noted its medications are approved by FDA for long-term use and include warning labels regarding their addiction risks. (Click for more...) FDA Commissioner Scott Gottlieb on ushering in new era of 3D printing of medical products 12/5/2017 9:00:01 AM December 05, 2017 FDA Commissioner Scott Gottlieb reports the agency is the first in the world to provide a comprehensive technical framework to advise manufacturers creating medical products on 3D printers. 3D printing of medical devices, medications, and human tissue is quickly becoming a promising reality. Patients have already benefited from 3D printed medical products through access to personalized devices and innovative drugs that have led to significant health improvements. But FDA is now preparing for a significant wave of new technologies that are nearly certain to transform medical practice. (Click for more...) FDA approves first biosimilar for the treatment of certain breast and stomach cancers 12/4/2017 9:00:01 AM December 04, 2017 FDA approved on December 1 trastuzumab-dkst (Ogivri— Mylan GmbH) as a biosimilar to trastuzumab (Herceptin—Genentech), for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene. This is the first biosimilar approved in the United States for the treatment of breast cancer or stomach cancer and the second biosimilar approved in this country for the treatment of cancer. (Click for more...) Clemastine fumarate as a remyelinating therapy for MS 12/4/2017 9:00:01 AM December 04, 2017 In this study, researchers sought to analyze the efficacy and safety of clemastine fumarate—a first-generation antihistamine—as a treatment for patients with multiple sclerosis (MS). They conducted a single-center, 150-day, double-blind, randomized, placebo-controlled, crossover trial (ReBUILD) in patients with relapsing MS with chronic demyelinating optic neuropathy on stable immunomodulatory therapy. (Click for more...) Mississippi, Alabama hospitals sue opioid manufacturers 12/4/2017 9:00:01 AM December 04, 2017 Hospitals in Mississippi and Alabama are suing more than a dozen pharmaceutical companies, claiming the companies deceptively marked and sold opioids. The class-action federal lawsuit was filed by Southwest Mississippi Regional Medical Center in McComb, MS; Infirmary Health Hospitals, Inc., based in Mobile, AL; and Monroe County Healthcare Authority, based in Monroeville, AL. (Click for more...) Express Scripts CEO sees Amazon as a potential pharmacy partner 12/4/2017 9:00:01 AM December 04, 2017 CNBC reported earlier this year that Amazon was hiring in an effort to figure out how to break into the pharmacy market. Express Scripts CEO Tim Wentworth says he sees Amazon as a potential partner, not a threat to Express Scripts' current share of the market. However, he warns that lowering consumer prices is not "the magic" of selling prescriptions online. "It's getting the right drug to consumers and helping them navigate the system—all things we've built a business over 30 years to do," Wentworth says. (Click for more...) CHPA recognizes Bayer for aspirin campaign 12/4/2017 9:00:01 AM December 04, 2017 The Consumer Healthcare Products Association's (CPHA) 2017 Industry Leadership Award for Advancing Self-Care has gone to Bayer Aspirin's "The HeroSmiths" marketing campaign, which seeks to educate people of the life-saving benefits of aspirin during a suspected heart attack. (Click for more...) GOP Medicaid work rules imperil care for opioid abusers 12/4/2017 9:00:01 AM December 04, 2017 Kentucky, New Hampshire, Maine and Indiana are among at least eight Republican-led states seeking federal approval to require Medicaid enrollees to work as a precondition of their health coverage. All four states have been hard hit by drug addiction. Governors say they would exempt people with chronic drug problems or severe mental illness from the Medicaid work requirements, but who would qualify and under what circumstances hasn’t been spelled out. Critics fear that many addicts could lose benefits, particularly if they go in and out of treatment, or have relapsed. (Click for more...) Battle continues over Medi-Cal pay to Ventura County area pharmacies 12/4/2017 9:00:01 AM December 04, 2017 Administrators of a Medi-Cal health plan said they will not push for lower prescription reimbursements despite complaints from independent pharmacists who say a sharp cut in payments over recent months may push some of them out of business. The conflict involves payments for medications in the publicly funded Gold Coast Health Plan. Gold Coast administers Medi-Cal health insurance to more than 200,000 low-income people in Ventura County. (Click for more...) House, Senate pass compromise bill on FDA, DoD emergency use authorizations 12/4/2017 9:00:01 AM December 04, 2017 Capitol Hill lawmakers have successfully diluted a measure that would have empowered the military to approve emergency use of medical products such as vaccines, platelet alternatives, and freeze-dried plasma. Based on what was viewed as FDA's slow movement on treatments that could help troops in crisis, the National Defense Authorization Act (NDAA) for fiscal year 2018 included language giving the Department of Defense (DoD) room to bypass the drug watchdog. (Click for more...) CVS to buy Aetna for $69 billion, reshaping health care industry 12/4/2017 9:00:01 AM December 04, 2017 CVS has agreed to buy Aetna for about $69 billion, in a deal that would reshape the American health care industry by bringing a big provider of pharmacy services and a large insurer under one roof. As part of the deal, CVS plans to use its nearly 10,000 pharmacy locations to provide consumers with more local care options. One of the biggest drivers of the deal is Amazon, which has laid the groundwork for an entry into the United States’ pharmacy business. As Amazon secures pharmacy licenses across the country, traditional drug sellers have weighed ways to fight back. (Click for more...) This company about to flood the U.S. with generic HIV drugs 12/4/2017 9:00:01 AM December 04, 2017 Beginning this month, U.S. patents on key ingredients in major HIV treatments will start to expire, opening the door for generic versions to enter the market. India-based Laurus Labs, boasting the industry's lowest production costs on antiretroviral drugs, believes it will be able to dominate the niche. With projected price drops of up to 90% off the cost of brand-name medicines, the company's CEO believes Laurus will perform well against bigger competitors like Teva Pharmaceuticals. (Click for more...) The Application of 3D Printing in the Formulation of Multilayered Fast Dissolving Oral Films 12/2/2017 6:05:01 PM December 02, 2017 Fast dissolving oral films (FDFs) provide an alternative approach to increase consumer acceptance by advantage of rapid dissolution and administration without water. Usually FDFs require taste-masking agents. However, inclusion of these excipients could make developing the formulation a challenging task. Hence, this work employed fused-deposition modelling three-dimensional (FDM 3D) printing to produce single-layered (SLFDFs), or multilayered (MLFDFs) films, with taste-masking layers being separated from drug layer. (Click for more...) FDA approves first once-monthly buprenorphine injection 12/1/2017 9:00:01 AM December 01, 2017 FDA approved on Thursday buprenorphine extended-release (Sublocade—Indivior), the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adults who have initiated treatment with a transmucosal buprenorphine-containing product. The drug is indicated for patients who have been on a stable dose of buprenorphine treatment for at least 7 days. "Given the scale of the opioid crisis, with millions of Americans already affected, the FDA is committed to expanding access to treatments that can help people pursue lives of sobriety. (Click for more...) Oral anticoagulants for prevention of stroke in atrial fibrillation 12/1/2017 9:00:01 AM December 01, 2017 Atrial fibrillation is estimated to cause more than a fifth of the 130,000 annual strokes in England and Wales. Patients with thromboembolic stroke from atrial fibrillation have higher mortality, higher morbidity, and longer hospital stays than patients with other stroke subtypes. Researchers in the United Kingdom conducted a systematic review of phase II or phase III randomized controlled trials that evaluated the use of a direct acting oral anticoagulant (DOAC), vitamin K antagonist, or antiplatelet agent for prevention of stroke in patients with atrial fibrillation. (Click for more...) Cancer drugs may offer new way to control high blood pressure 12/1/2017 9:00:01 AM December 01, 2017 Georgetown University Medical Center investigators have published a study in Hypertension suggesting that drugs for blocking cancer growth could also control hypertension. The study found that fibroblast growth factors (FGFs) that enable cancers to grow by intensifying the growth of blood vessels also have a systemic effect on blood pressure. The study's senior investigator, Georgetown's Anton Wellstein, MD, PhD, and colleagues found that a protein called FGFBP1 modulates FGF, and the gene that produces FGFBP1 to regulate FGF is known as FGF binding protein 1. (Click for more...) Evidence-based approach to treating post-delivery pain in new moms during opioid crisis 12/1/2017 9:00:01 AM December 01, 2017 Stanford University researchers say their study results show that opioid-based pain management often is unnecessary after childbirth, depending on how the baby is delivered. The investigation tracked pain, opioid use, and pace of recovery for 6 weeks post-partum in 213 healthy first-time mothers. Nearly a third of those who delivered vaginally required opioids for a brief time while hospitalized; however, most discontinued use after just 1 day and fewer than 10% still needed them after being discharged. Their pain was resolved in a median 14 days. (Click for more...) CVS Health closes in on deal to buy Aetna 12/1/2017 9:00:01 AM December 01, 2017 CVS Health is reportedly moving closer to a deal to buy Aetna for more than $66 billion in cash and stock. The deal could be announced by Monday. The companies are in advanced stages of negotiating a deal, according to people familiar with the matter. It is still possible the timing could slip or that the companies will fail to reach a deal. A merger would lock in a huge number of Aetna's members for CVS’s PBM as well as potential customers for its community pharmacies. That could bolster its leverage in negotiations with drugmakers. (Click for more...) California survey finds physicians, pharmacists comply with prescription drug monitoring law 12/1/2017 9:00:01 AM December 01, 2017 A law requiring California's physicians and pharmacists to register for the state's prescription drug monitoring program by July 2016 significantly increased registration rates, according to a new report by the UC Davis Violence Prevention Program. The survey, conducted from August 2016 to January 2017, reviewed the expanded functions of the Controlled Substance Utilization Review and Evaluation System (CURES). The study found that 96% of pharmacists and 82% of physicians surveyed had registered for CURES, compared with about one-half of pharmacists and one-fourth of physicians in 2015. (Click for more...) Veterans are key as surge of states OK medical pot for PTSD 12/1/2017 9:00:01 AM December 01, 2017 Twenty-eight states and the District of Columbia now include post-traumatic stress disorder (PTSD) in their medical marijuana programs, a number that has more than doubled in the last 2 years, according to data compiled by the pro-legalization Marijuana Policy Project. The increase has come amid increasingly visible advocacy from veterans' groups. (Click for more...) Air Force pharmacists support deployed missions 12/1/2017 9:00:01 AM December 01, 2017 Air Force pharmacists provide vital medical support in deployed settings around the world, from filling prescriptions to administering drugs. One of the most critical roles these pharmacists play is ensuring that their clinics have the correct medication inventory. The logistics chain for delivering new prescription drugs to the Middle East, for example, is much longer and more complicated than for a U.S. pharmacy, so if a clinic runs out of certain drugs, they may not be able to treat patients. Another key area for deployed Air Force pharmacists is fatigue management. (Click for more...) Diabetes care improvement in pharmacist- vs. nurse-supported patient-centered medical homes 12/1/2017 9:00:01 AM December 01, 2017 Both pharmacist- and nurse-led self-management support (SMS) approaches in patient-centered medical homes (PCMHs) improved diabetes care, according to a new study. The longitudinal cohort study compared the effectiveness of the two chronic disease SMS approaches, either pharmacist- or nurse-led, within the University of Michigan Health System (UMHS) over 2.5 years. (Click for more...) National science panel calls for aggressive steps to control drug prices 12/1/2017 9:00:01 AM December 01, 2017 A panel of the National Academies of Sciences, Engineering, and Medicine is recommending that the United States take urgent steps to control prescription drug prices. In a new report, the panel warns that the nation's prescription drug market is failing millions of sick individuals. The report takes aim at several practices in the pharmaceutical industry, including direct-to-consumer marketing and efforts by drug companies to block and delay the introduction of cheaper generic drugs. (Click for more...) U.S. health regulator Verma eyes new methods for drug pricing 12/1/2017 9:00:01 AM December 01, 2017 CMS head Seema Verma said Thursday the agency is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases. "We are trying to do whatever we can to increase competition and give the (health insurance) plans more tools so that they can be better negotiators on our behalf," Verma said. (Click for more...) FDA to allow quicker approval of some promising cancer drugs 12/1/2017 9:00:01 AM December 01, 2017 FDA Commissioner Scott Gottlieb, MD, said Thursday his agency intends to allow faster approval of some cancer drugs if they demonstrate early and "outsized" survival benefits for patients, even in small studies. Speaking to the House Energy and Commerce subcommittee on health, Gottlieb predicted FDA would see this situation more. (Click for more...) Pharmacy residency program ASHP accredited 12/1/2017 12:00:00 AM WVU Medicine Jefferson Medical Center's pharmacy residency program has been approved for accreditation by the American Society of Health-System Pharmacists (ASHP). (Click for more...) Addiction w/ Jake Nichols 11/30/2017 5:21:00 PM November 30, 2017 (Click for more...) CDC picks APhA Foundation to put diabetes prevention program in pharmacies 11/30/2017 10:54:30 AM November 30, 2017 CDC has selected the APhA Foundation, in partnership with the Kroger Co. and Solera Health, to build infrastructure within community pharmacies to expand access to an innovative evidence-based lifestyle change program designed to prevent or delay the onset of type 2 diabetes among adults with prediabetes. Called Project IMPACT: Diabetes Prevention, the program will deliver the CDC-recognized National Diabetes Prevention Program (National DPP) curriculum to at least 7,500 at-risk adults in underserved communities in the United States over the next 5 years. (Click for more...) Scaling the National Diabetes Prevention Program in Underserved Areas Through Pharmacies 11/30/2017 9:40:32 AM November 30, 2017 The American Pharmacists Association (APhA) Foundation today announced it has entered into a cooperative agreement with the Centers for Disease Control and Prevention (CDC) to build infrastructure within community pharmacies that will expand access to the National Diabetes Prevention Program’s (National DPP) evidence-based lifestyle change program designed to prevent or delay the onset of type 2 diabetes among adults with prediabetes. (Click for more...) New FIP report on the role of pharmacists in reducing harm associated with drugs of abuse includes marijuana 11/30/2017 9:00:01 AM November 30, 2017 A new report from the International Pharmaceutical Federation (FIP) describes the value of involving pharmacists in reducing harm from drugs of abuse in different regions and countries, including Europe, the United States, and the Middle East. (Click for more...) Updated Medicare Part D opioid drug mapping tool unveiled 11/30/2017 9:00:01 AM November 30, 2017 CMS introduced on Wednesday an updated version of the Medicare opioid prescribing mapping tool. The interactive, web-based resource visually presents geographic comparisons of Medicare Part D opioid prescribing rates, including extended-release opioid prescribing rates and county-level hot spots and outliers. (Click for more...) Fremanezumab for the preventive treatment of chronic migraine 11/30/2017 9:00:01 AM November 30, 2017 The results of a 12-week study indicate that fremanezumab as a preventive treatment for chronic migraine resulted in a lower frequency of headache compared with placebo. For the Phase III trial, 1,130 individuals with chronic migraine were randomly assigned to receive to fremanezumab quarterly, fremanezumab monthly, or placebo. The mean number of baseline headache days per month was about 13 in all three groups. The data show that fremanezumab quarterly reduced the average number of headache days per month by 4.3 days, while fremanezumab monthly led to a 4.6-day reduction. (Click for more...) A controlled trial of erenumab for episodic migraine 11/30/2017 9:00:01 AM November 30, 2017 Subcutaneous administration of erenumab at a monthly dose of 70 mg or 140 mg significantly reduced migraine frequency, the effects of migraines on daily activities, and the use of acute migraine-specific medication over 6 months, new research shows. For the study, 955 individuals were randomized to the 70-mg erenumab group, the 140-mg erenumab group, or to the placebo group. In the overall population, the mean number of migraine days per month was 8.3 at baseline. (Click for more...) HHS nominee Alex Azar testifies on government role in lowering drug costs 11/30/2017 9:00:01 AM November 30, 2017 Alex Azar, the Trump administration's nominee to become the next HHS secretary, testified Wednesday that prescription drug prices are too high and that the federal government has a role in trying to make medicine more affordable for consumers. The focus on costs during Azar's hearing before the Senate Health, Education, Labor and Pensions Committee reflected an attempt to get ahead of criticism that the decade he spent as a top executive at Eli Lilly makes him ill-equipped to address the issue of drug prices. (Click for more...) Lawmakers step off Capitol Hill to explore solutions to opioid crisis 11/30/2017 9:00:01 AM November 30, 2017 The House Oversight and Government Reform Committee met at Johns Hopkins Hospital in Baltimore on Tuesday to discuss the growing opioid crisis. Ranking Member Elijah Cummings (D-MD) said naloxone should be available to anyone who needs it, but that drug companies continue to raise the price of the drug and "communities have been forced to ration it." Gov. Chris Christie of New Jersey, chairman of the President's Commission on Combating Drug Addiction and the Opioid Crisis, suggested governments buy naloxone in bulk. (Click for more...) Study reveals patients at high risk for opioid overdose deaths 11/30/2017 9:00:01 AM November 30, 2017 A new study by researchers at Columbia University Medical Center (CUMC) is the first to determine the proportion of people who died from an opioid overdose with chronic pain. The findings were published in the American Journal of Psychiatry. Researchers analyzed clinical diagnoses and filled medication prescriptions between 2001 and 2007 for more than 13,000 adults enrolled in Medicaid who died of an opioid analgesic overdose. (Click for more...) The 'perfect storm' that hampers stewardship 11/30/2017 9:00:01 AM November 30, 2017 Despite approvals of newer antibiotics, resistance to such agents by gram-negative bacteria poses a significant problem. Expanding efforts in antimicrobial stewardship (AMS) call for the appropriate—and sparing—use of antimicrobial agents. A new standard from the Joint Commission, effective January 1, 2017, requires hospitals and nursing homes to establish and prioritize AMS programs but does not take into account antimicrobial susceptibility testing (AST). (Click for more...) Pfizer pays $94 million to resolve allegations it made fraudulent patents to delay generic competition 11/30/2017 9:00:01 AM November 30, 2017 To resolve allegations over Pfizer's use of fraudulent patents to delay generic competition for its anti-inflammatory drug celecoxib (Celebrex), the company has agreed to pay $94 million. A lawsuit was brought by 32 direct purchasers of Celebrex in April and certified as a class action lawsuit in August, claiming that Pfizer attempted to revive its invalidated patent by making material misrepresentations to the U.S. Patent and Trademark Office (PTO). As a result, the PTO granted Pfizer a new patent based on this reportedly inaccurate information. (Click for more...) Patients with rare diseases and Congress square off over orphan drug tax credits 11/30/2017 9:00:01 AM November 30, 2017 House Republicans earlier this month proposed eliminating the orphan drug tax credits, which Congress passed as part of a basket of financial incentives for drugmakers in the 1983 Orphan Drug Act. The law gives 7 years of market exclusivity for drugs that treat a specific condition that affects fewer than 200,000 people. The Senate Finance Committee, led by Sen. Orrin Hatch (R-UT), put the tax credit back into the current tax legislation. (Click for more...) Advancing medicinal nicotine replacement therapies as new drugs 11/30/2017 9:00:01 AM November 30, 2017 FDA announced Wednesday the formation of a new Nicotine Steering Committee that will be tasked with re-evaluating and modernizing the agency's approach to development and regulation of nicotine replacement therapy (NRT) products that help people quit smoking. The committee's primary focus will be therapeutic nicotine products for combustible tobacco product cessation. According to FDA, "This reflects the need to critically examine the evolving science behind FDA's evaluation of the safety and efficacy of NRTs. (Click for more...) Sessions and Patterson announce new tools to address opioid crisis 11/30/2017 9:00:01 AM November 30, 2017 U.S. Attorney General Sessions and acting DEA Administrator Robert Patterson on Wednesday announced new resources and stepped up efforts to address the drug and opioid crisis. Sessions reported there will be more than $12 million in grant funding to assist law enforcement in combating illegal manufacturing and distribution of methamphetamine, heroin, and prescription opioids. A new DEA Field Division in Louisville, KY, will be established, which will include Kentucky, Tennessee, and West Virginia, a move meant to better align DEA enforcement efforts within the Appalachian mountain region. (Click for more...) Community pharmacists may close gaps in depression screening for people with diabetes 11/30/2017 8:55:16 AM November 30, 2017 Community pharmacists can help ensure that people with diabetes are adequately screened and treated for depression, say researchers in a study published online in the Journal of the American Pharmacists Association. (Click for more...) Frequency of HIV testing and time from infection to diagnosis improve 11/29/2017 9:00:01 AM November 29, 2017 HIV is being diagnosed sooner after infection than was previously reported, with an estimated median of 3 years from HIV infection to diagnosis in 2015, according to a new report. CDC previously estimated that, in 2011, the median time from infection to diagnosis was 3 years and 7 months. The report noted that 85% of the estimated 1.1 million people living with HIV were aware of their infection. (Click for more...) Global response to malaria at crossroads 11/29/2017 9:00:01 AM November 29, 2017 Following significant global success in malaria control, progress has stalled, the World Malaria Report 2017 indicates. According to the report, there were an estimated 5 million more malaria cases last year compared with 2015. In addition, malaria deaths totaled about 445,000, compared with 446,000 in the previous year. "In recent years, we have made major gains in the fight against malaria," said Tedros Adhanom Ghebreyesus, MD, director-general of the World Health Organization. "We are now at a turning point. (Click for more...) Selective androgen receptor modulators sold via the internet 11/29/2017 9:00:01 AM November 29, 2017 Chemical analyses of more than three dozen products marketed as selective androgen receptor modulators and sold via the internet indicate that most of the products contained unapproved drugs and substances. The investigation was conducted in response to reports of growing use of nonsteroidal selective androgen receptor modulators—which are not approved by FDA—purchased through the internet by athletes, recreational bodybuilders, and members of the armed forces. (Click for more...) Cost of pneumococcal vaccine keeps rising 11/29/2017 9:00:01 AM November 29, 2017 Although the formulation of the pneumococcal 13-valent vaccine (Prevnar 13—Pfizer) has remained mostly unchanged since receiving federal approval in 2010, the price has continued to increase. In 8 years, the vaccine's cost has increased by more than 50%. The Advisory Committee on Immunization Practices recommends Prevnar 13 for all children younger than age 2 years—given at 2, 4, 6, and 15 months—as well as for adults aged 65 years and older. Doctors and clinics purchase the vaccine and then, after administering it to patients, usually recoup the cost through patients' insurance. (Click for more...) Early breastfeeding success not affected by epidural pain relief with fentanyl 11/29/2017 9:00:01 AM November 29, 2017 Contrary to earlier findings, new research results suggest that epidurals using fentanyl do not reduce the odds of successful breastfeeding. Investigators at Northwestern University randomized a sample of expecting women to receive their epidural with just the local anesthetic bupivacaine or with bupivacaine plus 1 or 2 micrograms per milliliter of fentanyl. All 345 participants had previously undergone labor epidural and had successfully breastfed in the past. (Click for more...) Pharmacists poised to ease physician shortage, if only they could get paid for it 11/29/2017 9:00:01 AM November 29, 2017 By some estimates, the United States will need at least 40,000 more doctors by 2030. The problem is even more pronounced in California's San Joaquin Valley, which is already home to 35% fewer primary care doctors than the federal government recommends. Pharmacists say they are now in a position to manage some of patients' medication-related needs, which would allow doctors to spend more time on other medical issues. But Lisa Kroon, chair of the department of clinical pharmacy at UC San Francisco, says the major obstacle still standing in their way is money. (Click for more...) CVS Health launches 'real-time benefits,' providing information across all points of care 11/29/2017 9:00:01 AM November 29, 2017 CVS Health on Tuesday announced that its PBM, CVS Caremark, will begin providing real-time visibility to member-specific medication costs and available lower-cost therapeutic alternatives at the point of prescribing and at the pharmacy. This enhanced visibility to the patient's benefit across all points of care can help eliminate potential dispensing delays, as well as improve patient outcomes through increased medication adherence. (Click for more...) FDA issues guidance that could make it easier for EpiPen rivals to come to market 11/29/2017 9:00:01 AM November 29, 2017 FDA on Tuesday announced guidance seeking to change that, potentially streamlining a path to market for generic copies of complex medicines like the EpiPen and others. The guidance says that generic copies with some design differences may be approved as substitutable products, as long as those differences do not affect patients' ability to use the product the way it is intended. "Those design differences might correlate with different instructions for use of the two products," said FDA Commissioner Scott Gottlieb. (Click for more...) Preventing drug abuse: Low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs 11/29/2017 9:00:01 AM November 29, 2017 Only 3% of the pharmacies and other entities eligible to maintain a prescription drug disposal bin for the public volunteer to do so, according to a new GAO report. A 2010 federal law permitted eligible entities, or those already approved by DEA to handle controlled substances, to voluntarily collect unused prescription drugs for disposal in an effort to reduce potential misuse by providing secure and convenient ways for people to dispose of their unused medications. (Click for more...) ISMP survey raises concerns about safety of text messaging medical orders 11/29/2017 9:00:01 AM November 29, 2017 The majority of health care professionals are concerned about possible safety risks of using text messaging for medical orders, according to a recent Institute for Safe Medication Practices (ISMP) survey. The 778 respondents were mostly pharmacists and nurses who practice in a hospital setting. The survey found that one-third of all respondents do not believe medical orders should ever be texted in health care. (Click for more...) Express Scripts sells unit with ties to a $35,000-a-vial drug 11/29/2017 9:00:01 AM November 29, 2017 Avista Capital Partners, a private equity firm, will buy Express Scripts' United BioSource division, the firms said in a statement. According to United BioSource's website, it helps "maximize product access and commercialization," helps drug companies "overcome access and adherence challenges," and provides drug testing services. In addition, United BioSource runs a program that gives away repository corticotropin injection (Acthar—Mallinckrodt Pharmaceuticals)—used to treat lupus, forms of arthritis, and other diseases—to patients who cannot afford it, Express Scripts said. (Click for more...) 1 in 10 medical products in developing countries is substandard or falsified 11/29/2017 9:00:01 AM November 29, 2017 The World Health Organization (WHO) reports that an estimated 1 in 10 medical products in low- and middle-income countries is either substandard or falsified. As a result, some people are taking medications that fail to treat or prevent disease, wasting money and also potentially causing serious health problems. "Substandard and falsified medicines particularly affect the most vulnerable communities," said Tedros Adhanom Ghebreyesus, MD, WHO director-general. He added, "This is unacceptable. (Click for more...) Investment in MTM services a win for Giant Eagle, patients, and payers 11/28/2017 10:37:46 AM November 28, 2017 Giant Eagle is a medium-sized chain, but when it comes to providing MTM services, it’s a titan. Its clinical program has racked up awards from health plans, vendors, and pharmacy organizations—including APhA—and continues to expand. What’s the secret to its success? Corporate support, a dedicated team of pharmacists and pharmacy technicians, and a healthy dose of competitive spirit. (Click for more...) Hospitals can improve high-alert med safety procedures with self-assessment 11/28/2017 10:33:45 AM November 28, 2017 Hospitals in the United States are required to identify and maintain active lists of high-alert medications, which isn’t hard to do. But when it comes to the next step of developing safety procedures for high-alert medications, the task can become more challenging. (Click for more...) Heated and deep-pocketed battle erupts over 340B drug discount program 11/28/2017 9:00:01 AM November 28, 2017 CMS struck a blow to the 340B drug discount program this month announcing a final rule to cut Medicare payments for hospitals enrolled in the program by 28%, or about $1.6 billion. The American Hospital Association and others quickly filed suit, arguing that the agency lacks the authority to slash the payments and that the rule undermines the intent Congress had when creating the program. Approximately 40% of U.S. hospitals now buy drugs through the program, according to a 2015 report from the Government Accountability Office. (Click for more...) Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes 11/28/2017 9:00:01 AM November 28, 2017 In this study, researchers sought to determine whether oral insulin delays onset of type 1 diabetes in autoantibody-positive relatives of patients with type 1 diabetes. Between March 2007, and December 2015, relatives with at least two autoantibodies, including insulin autoantibodies, and a median age of about 8 years were enrolled in several European countries, Canada, the United States, Australia, and New Zealand. The study included 560 individuals, including 389 participants in the primary analysis who were first- and second-degree relatives of patients with type 1 diabetes. (Click for more...) Sun Pharmaceutical Industries recalls two lots of metformin hydrochloride oral solution 11/28/2017 9:00:01 AM November 28, 2017 Sun Pharmaceutical Industries announced a recall of two lots of metformin hydrochloride oral solution (Riomet) that were found to be contaminated with Scopulariopsis brevicaulis. The contamination was noted during sample preparation for Antimicrobial Preservative Effective Testing being conducted as part of the 12-month stability study interval. Sun Pharmaceutical noted that use of the affected product could potentially result in a risk of infection, particularly in immunocompromised individuals. The most plausible portal of entry of S. (Click for more...) Low-dose aspirin as adjuvant treatment for venous leg ulceration 11/28/2017 9:00:01 AM November 28, 2017 In a new study, researchers from New Zealand investigated the effects of low-dose aspirin on ulcer healing in patients with venous leg ulcers. The study, conducted at five community nursing centers, involved adults with venous leg ulcers who could safely be treated with aspirin or placebo. In all, 125 participants were randomized to receive 150 mg oral aspirin daily and 126 received matching placebo for up to 24 weeks treatment, with compression therapy as standard background treatment. (Click for more...) Influenza widespread in at least 2 states, CDC says 11/28/2017 9:00:01 AM November 28, 2017 CDC's weekly influenza surveillance report indicates that a number of states are reporting localized influenza activity, and at least two states say it is widespread. For the week ending November 18, Oklahoma and Louisiana are labeled "widespread" on the influenza map. CDC noted that regional influenza activity was reported by Guam and six states (Arkansas, Georgia, Kentucky, Massachusetts, Mississippi, and South Carolina). Twenty states have reported local influenza activity, and only one state (West Virginia) has reported no influenza activity yet. (Click for more...) Walgreens study finds results from pharmacy, specialty clinic collaboration 11/28/2017 9:00:01 AM November 28, 2017 Approximately 94% of hepatitis C patients who were prescribed direct-acting antiretrovirals (DAAs) were able to achieve the primary outcome goal, sustained virologic response (SVR), even though many patients had advanced liver disease, previous treatment failure, or previous liver transplants, according to a recent Walgreens Center for Health and Wellbeing Research study assessing a collaboration between Piedmont Healthcare's hepatitis C specialty clinic and a Walgreens local specialty pharmacy. (Click for more...) Rite Aid announces first closings of asset sale to WBA 11/28/2017 9:00:01 AM November 28, 2017 Rite Aid said Monday that it has completed the pilot closing and first subsequent closings as part of its asset purchase agreement with Walgreens Boots Alliance (WBA). Under the amended and restated agreement, WBA will purchase a total of 1,932 stores, 3 distribution centers, and related inventory from Rite Aid for an all-cash purchase price of $4.375 billion on a cash-free, debt-free basis. Rite Aid and WBA plan to continue transferring ownership of these stores in phases in the coming months. They expect to complete all of the store transfers by Spring 2018. (Click for more...) U.S. House panel convenes in Baltimore to assess opioid epidemic 11/28/2017 9:00:01 AM November 28, 2017 A U.S. House panel will meet in Baltimore on Tuesday to help identify solutions to the deadly opioid epidemic. Rep. Elijah E. Cummings, the ranking Democrat on the House Oversight and Government Reform Committee, sought the field hearing with experts representing President Trump's Commission on Combating Drug Addiction and the Opioid Crisis and other national and local public health officials. At the hearing, to be held at Johns Hopkins Hospital, the panel expects to hear from Gov. (Click for more...) New Hampshire lawmakers recommend pharmacists prescribe birth control 11/28/2017 9:00:01 AM November 28, 2017 A commission appointed by the New Hampshire State Legislature voted unanimously last week to endorse allowing pharmacists to prescribe birth control. Pharmacists in California, Oregon, and Washington State are currently able to prescribe contraceptives. State Sen. (Click for more...) Pharmacists set to keep dispensing opioid overdose drug 11/28/2017 9:00:01 AM November 28, 2017 Lt. Gov. Brian Calley of Michigan announced on November 21 that an emergency rule allowing pharmacists in the state to dispense naloxone has been extended into 2018. In May, Gov. Rick Snyder requested that the state Department of Licensing and Regulatory Affairs establish an emergency rule that permitted registered pharmacies to dispense naloxone without a prescription from an individual's physician. (Click for more...) DEA mandates reduction in opioid manufacturing for 2018 11/28/2017 7:42:35 AM November 28, 2017 DEA’s finalized annual aggregate production quotas (APQs) for 2018 mandate a 20% reduction in the amount of opiate and opioid medication—including oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, codeine, meperidine, and fentanyl—that may be manufactured in 2018. Quotas are aimed at preventing a diversion while simultaneously satisfying annual needs. (Click for more...) Thermodynamic Estimate of the Number of Solvent Molecules Displaced by a Solute Molecule for Enthalpy-Driven Adsorption: Phenobarbital and Activated Carbons as the Model System 11/28/2017 12:05:01 AM November 27, 2017 A Modified Crisp Equation, describing the differential Gibbs free energy of the adsorption process, is being proposed, which considers multiple sites available on the surface for adsorption and their relative fractions. The differential Gibbs free energy can be calculated by the van’t Hoff Equation, which depends on the affinity constant in the Langmuir-Like Equation. To consider the number of solvent molecules displaced by a solute molecule in the adsorption process, a new derivative of the Langmuir-Like Equation is being proposed as well. (Click for more...) Hepatitis B vaccine, recombinant (adjuvanted) (Heplisav-B) 11/27/2017 10:14:56 PM November 27, 2017 (Click for more...) Startup could bring back Vioxx for hemophilia 11/27/2017 9:00:01 AM November 28, 2017 Small startup Tremeau Pharmaceuticals is engineering a comeback of Vioxx, which at one time delivered pain relief to millions of people with arthritis or other chronic pain. The former Merck & Co. product was taken off the market in 2004 after it was found to significantly inflate the risk of heart attack or stroke, but Tremeau is angling to reintroduce it as a treatment for severe joint pain associated with hemophilia. Vioxx has already received an orphan drug classification from U.S. regulators and could be approved within a few years, after patient testing has been conducted. (Click for more...) UPS makes curious move involving prescription drug business with new license 11/27/2017 9:00:01 AM November 27, 2017 United Parcel Service has acquired a manufacturing pharmacy license from Georgia's Board of Pharmacy, enabling the company to not only ship pharmaceuticals, but to relabel them. A UPS spokesperson said the move was part of standard operating procedure in order to remain compliant with federal law. The new license could also be required if UPS wanted to add an insert to a shipping package, the spokesperson noted. "If you're Merck and you've got all this product, you need someone to kind of manage that," said Stephen Buck, a drug supply chain expert and cofounder of Courage Health. (Click for more...) Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice 11/27/2017 9:00:01 AM November 27, 2017 Because asthma management is largely based on trial results from highly selected patient populations, U.K. researchers hypothesized that evidence from randomized trials—which better reflect usual clinical practice—might improve outcomes. They performed such an investigation involving adult patients who were already on maintenance inhaler therapy after being diagnosed with symptomatic asthma by a general practitioner. Participants started on a regimen of fluticasone furoate plus vilanterol or of optimized standard care. (Click for more...) As malaria resists treatment, experts warn of global crisis 11/27/2017 9:00:01 AM November 27, 2017 A new, drug-resistant strain of malaria, impervious to the two-drug combination tablets containing artemisinin and another popular drug with which it is frequently paired, piperaquine, threatens to upend years of worldwide eradication efforts—straining health care systems and raising the prospect that the death toll could increase again. In recent years, public health officials have tracked the spread of deadly falciparum malaria parasites from Cambodia to Thailand and Laos, and most recently into Vietnam. (Click for more...) FDA warns against 'do it yourself' gene therapy kits 11/27/2017 9:00:01 AM November 27, 2017 FDA is cautioning against the use of "do it yourself" gene therapy kits. In a statement posted on the agency's website, FDA warns that it is illegal to sell gene therapy products and kits intended for self-administration. (Click for more...) As health care changes, insurers, hospitals and pharmacies team up 11/27/2017 9:00:01 AM November 27, 2017 Now that federal officials have quashed the mega-mergers proposed by the biggest insurers and blocked a deal between two large community pharmacy chains, established players in the health care industry are venturing beyond their traditional lines of business. Companies are actively looking for partners that will provide an entree into new businesses or a new supply of customers. CVS Health, which started as a community pharmacy chain, operates a large PBM as well as walk-in clinics in its stores. (Click for more...) Missouri pharmacists show off pseudoephedrine tracking system 11/27/2017 9:00:01 AM November 27, 2017 The Missouri Pharmacy Association demonstrated on Wednesday a system that tracks the sale of pseudoephedrine. Joined by leaders of Greene County, MO, the pharmacists demonstrated how the National Precursor Log Exchange, or NPLEx, blocks sales of the key ingredient used to make methamphetamine. The real-time system, which is used in 33 states, has blocked the sale of more than 25,000 boxes of pseudoephedrine through September of this year. (Click for more...) White House: Opioid epidemic carries $504 billion price tag 11/27/2017 9:00:01 AM November 27, 2017 The president's Council of Economic Advisers estimates the opioid epidemic put a $504 billion drain on the country in 2015—a rapid escalation from $78.5 billion in costs cited in a private White House analysis just 2 years earlier. The more than six-fold increase in part reflects efforts to better capture lost opportunities resulting from opioid-related deaths, especially among the working-age population. (Click for more...) A qualitative study of patient involvement in medicines management after hospital discharge 11/27/2017 9:00:01 AM November 27, 2017 U.K. investigators studied how patients can take charge after being released from the hospital, so that their medicines management is not disrupted or compromised. For the research, the team from the University of Bradford conducted qualitative interviews with cardiology patients 6 weeks after hospital discharge. Of 60 who participated, responses from 23 revealed two primary themes. Under one, patients anticipated—and moved to avert—snags in the medicine supply chain. (Click for more...) Alex Azar raised drug prices at Eli Lilly. Can he lower them for the U.S.? 11/27/2017 9:00:01 AM November 27, 2017 Alex Azar, President Trump's nominee to lead HHS, is expected to face tough questions at a Senate confirmation hearing this week over why Eli Lilly raised drug prices under his leadership. Democratic senators say that, as a top manager at Eli Lilly and Company, he was responsible for steep increases on insulin and other drugs. How he would now address that issue as secretary of HHS is expected to dominate the hearings. Azar has struck a conciliatory tone as the public outcry over pharmaceutical prices has grown. (Click for more...) Pharmacists start campaign to lower prescription drug prices 11/27/2017 9:00:01 AM November 27, 2017 Michigan pharmacists have started a campaign to lower the cost of prescriptions. "Becomes rather frustrating for the community pharmacist," says Larry Wagenknecht, CEO of the Michigan Pharmacists Association (MPA). Wagenknecht blames high drug prices on PBMs. MPA notes PBMS are not licensed or regulated. But when pharmacies enter a contract with them, those languages in those contracts prevent pharmacists from telling customers about more affordable prescriptions. (Click for more...) FDA begins adding suffixes to newly approved biologics' names 11/27/2017 9:00:01 AM November 27, 2017 FDA recently began adding four-letter meaningless suffixes at the end of newly approved biologics' nonproprietary names, reflecting a shift in policy from only adding the suffixes to biosimilars' nonproprietary names since 2015. One of the first additions of the suffixes came on November 16, when FDA approved emicizumab-kxwh (Hemlibra-Roche). FDA finalized guidance in January on how biosimilars and their biologic reference products' names should include this four-letter suffix at the end of the nonproprietary name. (Click for more...) Diplomat to buy pharmacy services company in Missouri 11/27/2017 9:00:01 AM November 27, 2017 Flint, MI-based Diplomat Pharmacy will pay $595 million for LDI Integrated Pharmacy Services, which includes specialty and mail order prescription fullfillment on its menu of offerings. By acquiring the Missouri company from Nautic Partners and Oak HC/FT Partners, Diplomat says it will position itself to evolve into a highly differentiated specialty company. The deal is slated to close in 30–60 days. (Click for more...) Editorial Advisory Board 11/10/2017 12:05:01 AM December 01, 2017 (Click for more...) Schools of Medicine and Pharmacy alumni are WVU 2017 Homecoming Award recipients 10/4/2017 12:00:00 AM Three School of Medicine alumni and a School of Pharmacy graduate are being recognized by the WVU Alumni Association as 2017 Homecoming Award recipients. (Click for more...) Discussion leaders named for Post-Charlottesville Town Hall 9/19/2017 12:00:00 AM Seven volunteer discussion leaders will take part in the Health Sciences-WVU Medicine Town Hall this Wednesday (Sept. 20) at noon in the Patteson Auditorium at WVU. (Click for more...) WVU, WV attorney general expand eighth grade drug prevention program 9/12/2017 12:00:00 AM West Virginia Attorney General Patrick Morrisey and West Virginia University have partnered to expand a program aimed at sharing drug abuse prevention information with eighth grade students in West Virginia. The initiative, launched in March with the West Virginia University School of Nursing, now also involves West Virginia University's School of Pharmacy and two other universities. (Click for more...) Student and faculty international travel grants available 9/1/2017 12:00:00 AM In honor of the legacy of a long-time staff member in WVU's Global Health Program, the Global Engagement Office (GEO) at Health Sciences is pleased to announce that the application period for the Nancy Sanders Memorial Student Travel Grant and the Nancy Sanders Memorial Faculty Research Abroad Grant is now open. (Click for more...) WVU health care simulation week kicks off Sept. 12 8/30/2017 12:00:00 AM September 12 kicks off national Health Care Simulation Week, and the WV STEPS Center welcomes visitors to a series of events highlighting simulation education. (Click for more...) WVU in the News - Study aims to increase effectiveness of opioid addiction treatment 8/15/2017 12:00:00 AM A new study being conducted at WVU is aimed at increasing the effectiveness of addiction treatment. As many as 20 percent of people addicted to opioids will not respond to the standard treatment of suboxone. Genetic background is one of several factors WVU and the West Virginia Clinical and Translation Science Institute will study to provide better more patient-specific addiction treatment. Get the full story on WV Always. (Click for more...) West Virginia health research gets $55 million boost 8/1/2017 12:00:00 AM MORGANTOWN, W.Va. – Recommitting themselves to bring the benefits of research out of labs and hospitals and into the lives of West Virginia people and communities, a coalition of federal agencies, universities, hospitals and clinics will develop dozens of efforts over the next five years to battle addiction and cancer and reduce the impact of cardiovascular and neurological diseases. (Click for more...) Academy of Excellence in Teaching and Learning applications being accepted 7/20/2017 12:00:00 AM The WVU Health Sciences Faculty Development Program is now accepting applications, CVs and biographies for the 2017 Academy of Excellence in Teaching and Learning. (Click for more...) WVCTSI and WVU research aims to increase addiction treatment effectiveness 7/13/2017 12:00:00 AM MORGANTOWN, W.Va. – Up to 20 percent of people with opioid use disorder may not respond to standard treatment. A new study at West Virginia University seeks to understand why. (Click for more...) Madhavan named to Fulbright Specialist Roster 7/10/2017 12:00:00 AM The U.S. State Department has added S. Suresh Madhavan, Ph.D., of the WVU School of Pharmacy to Fulbright Specialist Roster for the next three years. (Click for more...) Leukemia Research Foundation supports cancer research at WVU 7/5/2017 12:00:00 AM The Leukemia Research Foundation has awarded $100,000 to Wei Du, M.D., Ph.D., of the West Virginia University Cancer Institute to investigate a method for increasing the effectiveness of stem cell transplantation. (Click for more...) Town Hall to focus on heart care and research Thursday, June 15 6/6/2017 12:00:00 AM Two WVU Medicine heart specialists will be the special guests at an open forum for Health Sciences and WVU Medicine faculty, staff, and students at noon on Thursday, June 15, in the Okey Patteson Auditorium in the Health Sciences Center. (Click for more...) Meet the Graduates: Lindsey Glotfelty 5/16/2017 12:00:00 AM When asked what she wanted people to know about her, Lindsey Glotfelty of Finzel, Maryland, stated it's not really what she wants people to know about her, but rather the messages she wants them to get. She has four lessons that she has learned in her life, and they are the principles by which she lives. (Click for more...) ASK WVU MEDICINE: Breast to Brain Cancer - Risks and Research 5/15/2017 12:00:00 AM Join Hannah Hazard-Jenkins, M.D. and Paul Lockman, Ph.D., doctors who are dedicating their efforts to research and treatment of breast cancer, at the next Ask WVU Medicine Community Conversation, Tuesday, May 23 at 6 p.m. in the WVU Health Sciences Center Fukushima Auditorium. (Click for more...) WVU School of Pharmacy's Suresh Madhavan recipient of Distinguished Pharmacy Alumni Award from Purdue University 5/9/2017 12:00:00 AM S. Suresh Madhavan, MBA, Ph.D., was the recipient of Purdue University College of Pharmacy's 2017 Distinguished Pharmacy Alumni Award. Dr. Madhavan was one of four Purdue alumni who received this award, which recognizes the recipient's outstanding achievements in professional and scientific endeavors. (Click for more...) Cancer researcher is first alum to lead WVU School of Pharmacy 4/26/2017 12:00:00 AM William (Bill) Petros, PharmD, FCCP, has been appointed to the position. (Click for more...) WVU recognizes Health Sciences staff and faculty 4/10/2017 12:00:00 AM West Virginia University honored 13 individuals and two teams at the Health Sciences Center for outstanding achievement on Wednesday, April 12 at 4 p.m. in the Pylons Lobby. (Click for more...) Frank Alderman, MD, to speak at WVU College of Business and Economics Distinguished Speaker Series 4/3/2017 12:00:00 AM Frank Alderman, MD, CEO of MedExpress and a graduate of the WVU Schools of Medicine and Pharmacy, will speak at the WVU College of Business and Economics's Distinguished Speaker Series on April 19 at 3:30 p.m. at the Morgantown Event Center. (Click for more...) WVU and WVCTSI fund two addiction projects 3/29/2017 12:00:00 AM MORGANTOWN, W.Va. – The West Virginia University (WVU) Addiction Task Force and West Virginia Clinical and Translational Science Institute (WVCTSI) have funded two new research projects to combat the opioid epidemic in the state. According to the Centers for Disease Control and Prevention, West Virginia continues to be devastated by this epidemic, having the highest rate of drug overdose deaths in the nation. (Click for more...) Vera Bradley Bingo Relay for Life fundraiser 3/28/2017 12:00:00 AM The West Virginia University School of Pharmacy Relay for Life Team and the Lambda Kappa Sigma student organization will be hosting a Vera Bradley Bingo at 1 p.m. on Sunday, April 2, in room 1909 at the WVU Health Sciences Center in Morgantown. Doors open at noon. (Click for more...) WVU health professions students provide information on fall risk prevention 3/24/2017 12:00:00 AM Students from the West Virginia University School of Pharmacy and School of Medicine Division of Physical Therapy visited Sundale Rehabilitation – Long Term Care on March 22 to discuss fall risk prevention. (Click for more...) FDA Outlines Conditions for Pharmacies to Repackage Drug Products 3/9/2017 7:00:00 PM A guidance issued by FDA on January 12 makes clear that the agency does not favor some long-standing habits of pharmacy personnel related to the repackaging of drug products. (Click for more...) Maine Pharmacists Eye Legislation to End Drug Plans' Retroactive Fees 3/9/2017 7:00:00 PM Direct and indirect remuneration (DIR) fees are a "dragon" that pharmacists in Maine are trying to slay, says Felicity Homsted, chief pharmacy officer for Penobscot Community Health Care (PCHC) in Bangor and president of the Maine Society of Health-System Pharmacists (MSHP). (Click for more...) Alabama Pharmacists Push for State Collaborative Therapy Law 3/9/2017 7:00:00 PM The February 7 start of Alabama's 2017 legislative session is a fresh opportunity for the state to codify collaborative drug therapy management (CDTM) as part of pharmacy practice. (Click for more...) HSC Interprofessional Education Week celebration is March 27-31 3/6/2017 12:00:00 AM Join us for the inaugural HSC Interprofessional Education Week celebration (Click for more...) New pharmacy scholarship honors longtime West Virginia pharmacist 3/6/2017 12:00:00 AM The Jack H. Smith Family Pharmacy Scholarship was established not only to honor Suzanne Smith-Fox's father, but to assist a student who holds the same values as her father – generosity, community involvement, quality citizenship and an outstanding passion for receiving an education. Jack was a 1956 graduate from the West Virginia University School of Pharmacy, and the endowed scholarship also honors Jack's father (Suzanne's grandfather) who was a pharmacist in Parkersburg, West Virginia. (Click for more...) Abuse Potential of Noncontrolled Drugs Often Overlooked, Official Says 2/26/2017 7:00:00 PM To get a real handle on drug abuse, clinicians need to look beyond opioids and consider the abuse potential of noncontrolled drugs, says Michael Cohen, operations officer for the investigations branch of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in Washington, D.C. (Click for more...) Updated Research Rule Aims for Friendlier Consent Process 2/26/2017 7:00:00 PM It's not just full-time researchers who need to grapple with the recently revised Common Rule, a federal regulation that underpins U.S. research involving human subjects. (Click for more...) Pharmacists Turn Naloxone Training Programs into Video for Broad Audience 2/26/2017 7:00:00 PM A pharmacy project to train emergency medical services (EMS) and law enforcement personnel in how to administer naloxone in cases of opioid overdose has grown into an educational effort that features a video aimed at any potential responder. (Click for more...) Family Focus Helps Pharmacist Improve Diabetes Care for Native Americans 2/12/2017 7:00:00 PM When Cherith Smith started work about a decade ago as a pharmacist at the Missoula Urban Indian Health Center in Montana, she saw a common thread of hopelessness in people with diabetes who visited the center. (Click for more...) VA Project Expands Clinical Pharmacy Services to Rural Veterans 2/12/2017 7:00:00 PM A major project at the Department of Veterans Affairs (VA) to position pharmacists as healthcare providers in rural settings is poised to generate new data on how pharmacists improve patient care. (Click for more...) Proposed Legislation, CMS Guidance Portend Advancements for Pharmacists 2/12/2017 7:00:00 PM Federal efforts to advance pharmacists' role in healthcare got off to a fast start in January with developments including the following: (Click for more...) Deflazacort Approved for Duchenne Muscular Dystrophy 2/9/2017 7:00:00 PM FDA and Marathon Pharmaceuticals LLC on February 9 announced the approval of deflazacort oral tablets and oral suspension for the treatment of Duchenne muscular dystrophy in patients 5 years of age or older. (Click for more...) WVU School of Pharmacy receives reaccreditation 2/9/2017 12:00:00 AM The West Virginia University School of Pharmacy's Doctor of Pharmacy (Pharm.D.) professional program recently received continued accreditation by the Accreditation Council for Pharmacy Education (ACPE). The accreditation is valid until 2025—a full eight years, which is the maximum length of time for ACPE's accreditation. (Click for more...) Baugh named director of interprofessional education for health sciences 12/19/2016 12:00:00 AM Gina M. Baugh, Pharm.D., associate professor and director of Introductory Pharmacy Practice Experiences at the West Virginia University School of Pharmacy, has been named director of interprofessional education for the WVU Health Sciences Center. (Click for more...) DEA registration renewal process changing 12/19/2016 12:00:00 AM As of January 1, 2017, those with an expired DEA registration will need to fully reapply; the DEA will no longer allow a grace period for expired registrants. (Click for more...) WVU Pharmacy students educate youth about substance and prescription drug abuse 10/31/2016 12:00:00 AM Second-year students at the West Virginia University School of Pharmacy visited West Preston School on Thursday, Oct. 27, to discuss the dangers of substance and prescription drug abuse. (Click for more...) WVU student pharmacists offer health screenings at Bridge Day 10/14/2016 12:00:00 AM MORGANTOWN, W.Va. — Students from the West Virginia University School of Pharmacy will be offering a variety of health screenings and information Saturday, Oct. 15, from 9 a.m. – 3 p.m. at Bridge Day at New River Gorge in Fayetteville, West Virginia. (Click for more...) WVU's food bank to open second location, The Rack II@HSC 10/6/2016 12:00:00 AM West Virginia University Health Sciences will soon open "The Rack II@HSC," WVU Health Sciences' Campus Food Bank, to assist with campus-wide efforts to address the growing population of homeless and/or hungry employees/students. (Click for more...) WVU Pharmacy student writes song to benefit disaster relief efforts 9/22/2016 12:00:00 AM MORGANTOWN, W.Va. — You never know from where a source of inspiration might come. (Click for more...) Griffith named WVU Medicine vice president of cancer services 9/21/2016 12:00:00 AM Niesha L. Griffith, a graduate of the West Virginia University School of Pharmacy, has returned to her alma mater as vice president of cancer services for WVU Medicine. She began her new role Sept. 13. (Click for more...) NIH awards WVU $1.8 million to widen health options for children 9/21/2016 12:00:00 AM Seriously ill children across West Virginia will have easier access to new medical treatments in their own communities, thanks to a four-year, $1.8 million grant awarded to West Virginia University today by the National Institutes of Health. (Click for more...) WVU to mark Morgantown Overdose Awareness Day with panel discussion 8/23/2016 12:00:00 AM Makalynn, a WVU student in a 12-step recovery program, is among the WVU and Morgantown representatives who will take part in a panel discussion at 7 p.m. Wednesday, Aug. 31, at the Mountainlair. (Click for more...) WVU Pharmacy students receive white coats 8/13/2016 12:00:00 AM When Deborah Pope of Martinsburg, West Virginia, was in middle school, she knew she wanted to be a health care professional when she grew up. A friend suggested becoming a pharmacist, and the more Pope researched the profession, she discovered it was the right career for her. (Click for more...) WV-INBRE program brings faculty and student researchers across the state to WVU and Marshall for research experience 8/10/2016 12:00:00 AM West Virginia University and Marshall University received a grant for approximately $16 million dollars in 2014 to be distributed over the course of five years from the National Institutes of Health (NIH) to support an Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE). (Click for more...) Change comes from within 8/8/2016 12:00:00 AM West Virginia University's responsibility as the state's Land Grant University is to use the power of knowledge and human connection to lift up people everywhere in our state. But as they say on airplanes, in an emergency you should put on your own oxygen mask first, before you attempt to help others. You can't be much help if you gasping for air. That's why WVU's vice president for health sciences has asked a group of leaders from across WVU Medicine and the Health Sciences Center – and outside our campus – to join the new Quality of Life Initiative. (Click for more...) WVU School of Pharmacy's Terry Schwinghammer recipient of national educator award 8/3/2016 12:00:00 AM Terry Schwinghammer, Pharm.D., was the recipient of the American Association of Colleges of Pharmacy (AACP) Robert K. Chalmers Distinguished Pharmacy Educator Award. (Click for more...) WVU offers free opioid use disorder training to West Virginia healthcare providers 7/20/2016 12:00:00 AM WVU is offering a free American Society of Addiction Medicine buprenorphine course, along with a one-day continuing education event, in two different locations in West Virginia – August 20 in Morgantown and September 17 in Charleston. (Click for more...) WVU Health Outcomes Ph.D. students receive accolades at international conference 6/17/2016 12:00:00 AM Graduate students in the West Virginia University School of Pharmacy Health Outcomes Research Ph.D. program were the recipients of several awards during the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting. The meeting was held May 21–25 in Washington, D.C. (Click for more...) Two from WVU named BioWV leaders 5/23/2016 12:00:00 AM Two WVU researchers have been named to the leadership of BioWV, the Bioscience Association of West Virginia, a nonprofit organization that promotes the state's growing bioscience business community. (Click for more...) West Virginia University offers courses to reduce opioid use 5/3/2016 12:00:00 AM West Virginia University has added a new online course, "The Treatment of Pain and Addiction Utilizing Education and Proper Prescribing: The New Paradigm Continued." The course will provide West Virginia physicians, physician assistants, nurses, and dentists with continuing education credit, and also fulfill the state's requirement for training in avoiding diversion of prescriptions drugs into the illicit market. (Click for more...) Wigner Institute hosts AADE workshop 4/20/2016 12:00:00 AM The WVU School of Pharmacy Wigner Institute for Advanced Pharmacy Practice, Education, and Research sponsored an American Association of Diabetes Educators Workshop on April 18. Attendees included pharmacists, nurses, and dietitians from clinics, hospitals, pharmacies, and health departments from 40 counties throughout the state. (Click for more...) WVU BOG approves new degree programs, receives update on Beckley campus 4/19/2016 12:00:00 AM The WVU Board of Governors gave final approval to repurpose an existing School of Pharmacy Ph.D. track into its own independent doctoral program, which will offer a new doctor of philosophy degree in health services and outcomes research. (Click for more...) Outstanding Graduate Student and Mentor awards ceremony 4/13/2016 12:00:00 AM On April 8, 2016, the Office of Research and Graduate Education recognized the achievements and participation of our graduate students in the research, teaching and service missions of the Health Science Center. As part of this ceremony, awards were given to faculty who are outstanding mentors and to graduate students who are outstanding in their graduate programs. (Click for more...) Inspiring Students 4/6/2016 12:00:00 AM I had a lot of fun recording some video with students from each of the Health Sciences schools Tuesday for a back to school video in the fall. (Click for more...) WVU student pharmacists host Senior Olympics 4/1/2016 12:00:00 AM Students from the West Virginia University School of Pharmacy hosted a Senior Olympics for local seniors to stress the importance of physical fitness. (Click for more...) Going global for health education 1/14/2016 12:00:00 AM Beginning in January 2016, faculty and students of the West Virginia University School of Pharmacy will gain a new global opportunity for education and collaboration. (Click for more...) Gold and Blue celebration in Oman 1/13/2016 12:00:00 AM More than 110 newly-graduated health professionals – decked out in West Virginia University's gold-and-blue colors – received diplomas from Oman Medical College Sunday (Jan. 10) in an outdoor ceremony at the Intercontinental Muscat Hotel. (Click for more...) Pack the Rack success 1/13/2016 12:00:00 AM WVU Health Sciences and WVU Medicine faculty, students, and staff donated 944 food items to The Rack – the WVU student food bank – during the "Pack the Rack" holiday drive in November and December, according to Jacqueline Dooley, The Rack program director. (Click for more...)
Copyright© 2017 West Virginia Society of Health System Pharmacists. All rights reserved.